发明名称 |
USE OF A CYTOKINE FROM THE INTERLEUKIN-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR COMBINED ADMINISTRATION WITH INTERFERON-ALPHA |
摘要 |
The invention relates to the use of at least one cytokine from the IL-6 family-gp130, preferably selected from among IL-11, the leukaemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1, ciliary neurotrophic factor (CNTF), the cardiotrophin-like cytokine (CLC) and combinations thereof or a DNA sequence encoding same, in the preparation of a pharmaceutical composition which is intended for combined administration with at least one interferon-alpha or a DNA sequence encoding same, for use in the treatment of viral diseases. The invention also relates to a pharmaceutical composition comprising a pharmaceutically-acceptable quantity of at least one cytokin from the IL-6 family-gp130 or a DNA sequence encoding same and a pharmaceutically-acceptable quantity of at least one interferon-alpha or a DNA sequence encoding same, a pharmaceutical kit and a method for the treatment of viral diseases with the combined administration of the aforementioned cytokines and interferon-alpha.
|
申请公布号 |
WO2006134195(A8) |
申请公布日期 |
2008.01.31 |
申请号 |
WO2006ES00353 |
申请日期 |
2006.06.16 |
申请人 |
PROYECTO DE BIOMEDICINA CIMA, S.L.;ALDABE ARREGUI, RAFAEL;LARREA LEOZ, ESTHER;CIVEIRA MURILLO, MARIA PILAR;PRIETO VALTUENA, JESUS |
发明人 |
ALDABE ARREGUI, RAFAEL;LARREA LEOZ, ESTHER;CIVEIRA MURILLO, MARIA PILAR;PRIETO VALTUENA, JESUS |
分类号 |
A61K38/20;A61K38/21;C07K14/54;C07K14/56 |
主分类号 |
A61K38/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|